Zobrazeno 1 - 10
of 201
pro vyhledávání: ''
Autor:
Jan-Stefan van der Walt, Joji Mori, Takahiro Nakayama, Kenichi Inoue, Yoshinori Ito, George W. Sledge, Yasuo Miyoshi, Tsutomu Kawaguchi, Masato Takahashi, Yoshinori Tanizawa, Masakazu Toi, Antonio Llombart-Cussac, Norikazu Masuda, Hiroji Iwata, Hirofumi Mukai, Sachi Sakaguchi
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background This was a Japanese subpopulation analysis of MONARCH 2, a double-blind, randomized, placebo-controlled, phase 3 study of abemaciclib plus fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-neg
Autor:
Masako Kataoka, Masakazu Toi, Kaori Togashi, Mami Iima, Akane Ohashi, Shotaro Kanao, Daniel Förnvik
Publikováno v:
European Radiology
To compare breast density measured on digital breast tomosynthesis (DBT) (BI-RADS-based breast composition and fully-automatic estimation) and magnetic resonance imaging (MRI) (BI-RADS amount of fibroglandular tissue), and to evaluate the diagnostic
Autor:
Miguel Gil-Gil, José A. García-Sáenz, E Dalmau Portulas, Elena García-Martínez, Nuria Ribelles, A. Santaballa Bertran, E. Martínez de Dueñas, I Alvarez-Lopez, Susana Bezares
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Clinical & Translational Oncology
Universidad de Barcelona
Clinical & Translational Oncology
PurposeHormone receptor (HR)-positive, Human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC) requires a therapeutic approach that takes into account multiple factors, with treatment being based on anti-estrogen hormo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b63a263cb82f360402dddafab187eefb
http://hdl.handle.net/2445/174389
http://hdl.handle.net/2445/174389
Autor:
Masako Sato, Hidetoshi Kawaguchi, Satoshi Morita, Makiko Mizutani, Yoshie Hasegawa, Ken-ichi Watanabe, Yasuaki Sagara, Fumikata Hara, Takashi Morimoto, Takahiro Nakayama, Norikazu Masuda, Mitsuya Itoh, Shoichiro Ohtani, Nobuki Matsunami, Kenji Higaki, Masato Takahashi, Tetsuhiro Yoshinami
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background This study aimed to investigate whether schedule modification is safe and effective in patients intolerant to the standard eribulin dose and schedule. Methods Patients with metastatic breast cancer (MBC) treated with both anthracycline and
Autor:
M. Bellet Ezquerra, S. Antolin Novoa, Mafalda Oliveira, E. Martínez de Dueñas, S. López-Tarruella Cobo, M. A. Segui Palmer, L. de la Cruz Merino, J. Gavila Gregori, I. Álvarez López, J. I. Chacón López-Muñiz
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Scientia
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Recercat. Dipósit de la Recerca de Catalunya
Clinical & Translational Oncology
instname
Scientia
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Recercat. Dipósit de la Recerca de Catalunya
Clinical & Translational Oncology
Recurrència loco-regional; Càncer de mama; Pautes Recurrencia loco-regional; Cáncer de mama; Pautas Loco-regional recurrence; Breast cancer; Guidelines Although the metastasic breast cancer is still an incurable disease, recent advances have incre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c99ab8f97d50d5114bc5b368698614ee
http://hdl.handle.net/10261/212722
http://hdl.handle.net/10261/212722
Autor:
J. F. García, Belén Pérez-Mies, María Ángeles López-García, P. Santiago, Begoña Vieites, Octavio Burgues, Vicente Peg
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
CLINICAL & TRANSLATIONAL ONCOLOGY
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
CLINICAL & TRANSLATIONAL ONCOLOGY
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
[Purpose] To compare the current international standards for neoadjuvant systemic therapy (NAST) protocols, and establish consensus recommendations by Spanish breast pathologists; and to look into the Spanish reality of defining pathological complete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6398a2b24cd3633adf6ac124f71756a
http://hdl.handle.net/10261/198758
http://hdl.handle.net/10261/198758
Autor:
Rezvan Esmaeili, Hassan Fazilaty, Ali-Akbar Zare, Mehrdad Asghari Estiar, Ali Zekri, Narges Jafarbeik-Iravani, Keivan Majidzadeh-A, Leila Farahmand
Carcinoembryonic antigen (CEA) family members play important roles in malignancies and are introduced as biomarkers in different types of cancers. Among them CEACAM19 (CEAL1) gene, a new member of the CEA family, remains to be fully elucidated. The a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1808b0df50460e3c4e3fc63b2eb78444
http://hdl.handle.net/10261/308379
http://hdl.handle.net/10261/308379
Autor:
Cecilia Gelfi, Luigi Minafra, Valentina Bravatà, Rossana Norata, Carmelo Lupo, Massimo Viola, Cristina Messa
Publikováno v:
BMC research notes 5 (2012): 343. doi:10.1186/1756-0500-5-343
info:cnr-pdr/source/autori:Luigi Minafra; Rossana Norata; Valentina Bravatà; Massimo Viola; Carmelo Lupo; Cecilia Gelfi; Cristina Messa./titolo:Unmasking epithelial-mesenchymal transition in a breast cancer primary culture: a study report./doi:10.1186%2F1756-0500-5-343/rivista:BMC research notes/anno:2012/pagina_da:343/pagina_a:/intervallo_pagine:343/volume:5
BMC Research Notes
BMC Research Notes, Vol 5, Iss 1, p 343 (2012)
info:cnr-pdr/source/autori:Luigi Minafra; Rossana Norata; Valentina Bravatà; Massimo Viola; Carmelo Lupo; Cecilia Gelfi; Cristina Messa./titolo:Unmasking epithelial-mesenchymal transition in a breast cancer primary culture: a study report./doi:10.1186%2F1756-0500-5-343/rivista:BMC research notes/anno:2012/pagina_da:343/pagina_a:/intervallo_pagine:343/volume:5
BMC Research Notes
BMC Research Notes, Vol 5, Iss 1, p 343 (2012)
Background Immortalized cancer cell lines are now well-established procedures in biomedicine for a more complete understanding of cellular processes in cancer. However, they are more useful in preparation of fresh tumour tissue, in order to obtain ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::879cc7aa8288ebe6181e5c13b2617698
http://hdl.handle.net/10281/37353
http://hdl.handle.net/10281/37353
Autor:
Helen M. Heneghan, Karl J. Sweeney, Ruth Prichard, Amanda Devaney, Ray McLaughlin, Michael J. Kerin, Carmel Malone
Publikováno v:
BMC Surgery, Vol 9, Iss 1, p 15 (2009)
BMC Surgery
BMC Surgery
Background Over the last decade there has been a paradigm shift in the management of breast cancer, subsequent to revised surgical oncology guidelines and consensus statements which were derived in light of landmark breast cancer clinical trials cond
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ff4b2c569e387b9d1ce19f09672e131
http://hdl.handle.net/10379/11897
http://hdl.handle.net/10379/11897
Autor:
Christian Schem, Dirk Bauerschlag, Thomas Löning, Olivera Batic, Katharina Tiemann, Walter Jonat, Martin H. Carstensen, Christian Röder, Nicolai Maass
Publikováno v:
Virchows Archiv. 454(2):203-210
Sentinel lymph node (SN) biopsy is part of the staging procedure in breast cancer patients. In this study, we compared an intraoperative tool named one-step nucleic acid amplification (OSNA) to our routine histological investigation. OSNA consists of